ArticleFOX A1 expression as a prognostic factor in cases of invasive serous and mucinous ovarian carcinoma in association with p53 status and CEA expression
ArticleFOX A1 expression as a prognostic factor in cases of invasive serous and mucinous ovarian carcinoma in association with p53 status and CEA expression
ArticleAssessment of prognostic value FOXA1 Expression in breast carcinoma after neoadjuvant chemotherapy: Immunohistochemically Study
ArticleAssessment of prognostic value FOXA1 Expression in breast carcinoma after neoadjuvant chemotherapy: Immunohistochemically Study
ArticleEpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study
ArticleEpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study
ArticleEGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
ArticleEGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
ArticleFOXP3 AND CD8 EXPRESSION IN DUCTAL CARCINOMA OF THE BREAST AND ITS RELATION TO THE CLINICOPATHOLOGICAL PARAMETERS
ArticleFOXP3 AND CD8 EXPRESSION IN DUCTAL CARCINOMA OF THE BREAST AND ITS RELATION TO THE CLINICOPATHOLOGICAL PARAMETERS
ArticleSignificance of expression of PD-L1, VEGF and CD8+ T cells in ovarian serous carcinoma: an Immunohistochemical study
ArticleSignificance of expression of PD-L1, VEGF and CD8+ T cells in ovarian serous carcinoma: an Immunohistochemical study
ArticleImmunohistochemical expression of FOXA1 and Androgen receptor in breast carcinoma in Upper Egypt
ArticleImmunohistochemical expression of FOXA1 and Androgen receptor in breast carcinoma in Upper Egypt